返回
Developing a New qPCR-Based System for Screening Mutation
DOI:10.1002/smll.201805285.png)
摘要
En 中文
An accurate genotyping analysis is one of the critical prerequisites for lung cancer targeted therapy. Here, a quantitative polymerase chain reaction (qPCR)-based mutation detection system, mutation-selected amplification-specific system PCR (MASS-PCR), is developed. The specific primers and probes used in MASS-PCR exactly match with the mutant sequence that only allows mutant gene to emit the fluorescence peak. To determine the sensitivity of MASS-PCR, 717 lung cancer specimens, 61 formalin-fixed paraffin-embedded (FFPE) tissues, and 656 fresh reaction tissues are collected and undergo mutation detection of lung cancer driver genes (EGFR, KRAS, BRAF, HER2, MET, ALK, and ROS1). These samples are divided into two groups. Mutations in Group I, which has 631 fresh reaction tissues, are analyzed by MASS-PCR and the amplification refractory mutation system PCR (ARMS-PCR). While group II samples, 25 fresh reaction tissues and 61 FFPE tissues, are screened through MASS-PCR and next-generation sequencing (NGS). All results are verified by direct sequencing. MASS-PCR shows high consistency with ARMS-PCR (kappa value > 0.733) and NGS (kappa value = 0.79) (P < 0.001). For the samples with inconsistent MASS-PCR and ARMS-PCR results, DS results more likely support the MASS-PCR results. These data suggest that MASS-PCR is a convenient, accurate, and economical method for the detection of lung cancer driver gene mutations in clinical practice.
Keyword:
amplification refractory mutation system PCR (ARMS-PCR)
direct sequencing
driver genes
mutation-selected amplification-specific system PCR (MASS-PCR)
next-generation sequencing
AI总结
对已上传原文的论文进行重点信息的提取,主要内容包括:简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
IF:
12.1
论文数:
3.0W
被引数:
16.4W
机构
引用论文
Understanding individual and socio-cultural factors associated with hispanic parents’ provision of sugar-sweetened beverages to young children
Appetite
IF0
Taking qPCR to a higher level: Analysis of CNV reveals the power of high throughput qPCR to enhance quantitative resolution
METHODS
IF4.3
2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer第二届ESMO肺癌共识会议: 局部晚期III期非小细胞肺癌
ANNALS OF ONCOLOGY
IF65.4
Replacing PCR with COLD-PCR enriches variant DNA sequences and redefines the sensitivity of genetic testing
NATURE MEDICINE
IF50
Matrix Methods for Solving Hartree-Fock Equations in Atomic Structure Calculations and Line Broadening
Atoms
IF0
Feasibility of an online intervention (STAK-D) to promote physical activity in children with type 1 diabetes: protocol for a randomised controlled trial
Trials
IF0
Reversal of established responses to endothelin‐1 in vivo and in vitro by the endothelin receptor antagonists, BQ‐123 and PD 145065内皮素受体拮抗剂,bq ‐ 123和PD 145065对内皮素-1 体内 和 体外 的既定反应的逆转

